Jason Whiting

Jason Whiting brings more than 25 years of medtech experience commercializing novel technologies, from implantable and wearable devices to capital equipment, including several therapies for patients with heart failure. Most recently, he served as CEO of Avation Medical, a medical device company advancing a wearable neuromodulation therapy for overactive bladder. Previously, he served for more than eight years as President of ZOLL Cardiac Management Solutions, following his role as Vice President of Global Marketing and Clinical Operations. Earlier in his career, Jason held various leadership positions in sales, marketing, and global business management at MEDRAD (now Bayer) and Guidant (now Boston Scientific). Jason holds an MBA from Michigan State University and a BBA from the University of Michigan.